Valion Bio, Inc. - 8-K Filing

Lisa Wolf to resign as President, COO, and CFO of Valion Bio, Inc. effective December 11, 2026 (Items: 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Offi)

SEC EDGAR ·

Tickers: $TIVC

Read the full article at SEC EDGAR

More Regulatory news